Ozempic Lawsuit – What is it About and Who Qualifies?
A significant development has emerged in the pharmaceutical industry, involving two major players, Novo Nordisk and Eli Lilly. These companies are facing a wave of lawsuits concerning their GLP-1 (glucagon-like peptide-1) medications, commonly used in the treatment of diabetes. GLP-1 medications, known for their efficacy in lowering blood glucose levels and aiding in weight management, have become a cornerstone in ...
